- CA$6.85bn
- CA$15.12bn
- CA$5.43bn
- 74
- 77
- 44
- 71
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 4,294 | 4,318 | 4,554 | 4,532 | 5,434 |
Cost of Revenue | |||||
Gross Profit | 2,580 | 2,588 | 2,658 | 2,631 | 2,993 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 3,194 | 3,209 | 3,451 | 3,380 | 4,158 |
Operating Profit | 1,100 | 1,109 | 1,104 | 1,152 | 1,277 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 767 | 790 | 785 | 810 | 863 |
Provision for Income Taxes | |||||
Net Income After Taxes | 561 | 584 | 588 | 597 | 635 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 653 | 607 | 578 | 600 | 651 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 652 | 602 | 568 | 600 | 651 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.25 | 2.33 | 2.51 | 2.6 | 2.92 |
Dividends per Share |